These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20828570)

  • 21. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.
    Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z
    Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.
    Stanietsky N; Simic H; Arapovic J; Toporik A; Levy O; Novik A; Levine Z; Beiman M; Dassa L; Achdout H; Stern-Ginossar N; Tsukerman P; Jonjic S; Mandelboim O
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17858-63. PubMed ID: 19815499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Concepts in Natural Killer Cell Biology and Application to Drug Safety Assessments.
    Goyos A; Fort M; Sharma A; Lebrec H
    Toxicol Sci; 2019 Jul; 170(1):10-19. PubMed ID: 31020324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural selection for killer receptors and their MHC class I ligands: In pursuit of gene pairs that fit well in tandem.
    Brown MG; Gamache A; Nash WT; Cronk J
    J Leukoc Biol; 2019 Mar; 105(3):489-495. PubMed ID: 30500089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human natural killer receptors, co-receptors, and their ligands.
    Biassoni R
    Curr Protoc Immunol; 2009 Feb; Chapter 14():14.10.1-14.10.40. PubMed ID: 19235767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cell education: Physiological and pathological influences.
    Rascle P; Woolley G; Jost S; Manickam C; Reeves RK
    Front Immunol; 2023; 14():1087155. PubMed ID: 36742337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of natural killer cell receptors.
    Carrillo-Bustamante P; Keşmir C; de Boer RJ
    Immunogenetics; 2016 Jan; 68(1):3-18. PubMed ID: 26392015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CD226, TIGIT and CD96 regulate NK cell function and participate in anti-tumor immunity].
    Zhang H; Liu R; Zhang Y; Liu X; Chen L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Sep; 39(9):852-856. PubMed ID: 37732582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Natural Killer Receptors, Co-Receptors, and Their Ligands.
    Biassoni R; Malnati MS
    Curr Protoc Immunol; 2018 Apr; 121(1):e47. PubMed ID: 30040219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution.
    Parham P; Moffett A
    Nat Rev Immunol; 2013 Feb; 13(2):133-44. PubMed ID: 23334245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor In Exosome-Mediated Cytotoxicity Against Tumor.
    Di Pace AL; Tumino N; Besi F; Alicata C; Conti LA; Munari E; Maggi E; Vacca P; Moretta L
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocytosis and intracellular trafficking of human natural killer cell receptors.
    Masilamani M; Peruzzi G; Borrego F; Coligan JE
    Traffic; 2009 Dec; 10(12):1735-44. PubMed ID: 19719476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment.
    Paolini R; Molfetta R
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balancing natural killer cell activation through paired receptors.
    Martinet L; Smyth MJ
    Nat Rev Immunol; 2015 Apr; 15(4):243-54. PubMed ID: 25743219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.
    Stanietsky N; Rovis TL; Glasner A; Seidel E; Tsukerman P; Yamin R; Enk J; Jonjic S; Mandelboim O
    Eur J Immunol; 2013 Aug; 43(8):2138-50. PubMed ID: 23677581
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.